By Claire Henchcliffe, MD
Assistant Professor of the Department of Neurology at Weill Medical College, Cornell University
Dr. Henchcliffe is on the speakers bureau for GlaxoSmithKline, Teva/Eisai, and Boehringer Ingelheim.
Synopsis: Depression and anxiety in Parkinsons disease might be associated with a specific loss of dopamine and noradrenaline innervation in the limbic system.
By Claire Henchcliffe, MD
Synopsis: Deep brain stimulation (DBS) is associated with significant improvement of motor complications in patients with severe Parkinsons disease after some 6-12 months of treatment.
Acute lower respiratory tract infection (bronchitis) is the most common complaint bringing patients to the doctor in England, where it is estimated that 75% of these patients receive an antibiotic at the first visit.
